Zydus Lifesciences Limited Febuxostat Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Febuxostat Export Records India — #14 Exporter, 22 Shipments, $398.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Febuxostat

India Pharmaceutical Trade Intelligence

$48.9M182 Suppliers91 CountriesHS 30049099

ExportsIndia → PHILIPPINES52.3%India → UNITED STATES23.7%

ImportsCHINA → India$10.6K UNITED STATES → India$5.5K

#1 Supplier: AJANTA PHARMA #1 Buyer: UNILAB INC

Zydus Lifesciences Limited — Febuxostat Exporter #14 | $398.4K Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Febuxostat Exporter Profile

Indian Pharmaceutical Exporter · #14 for Febuxostat · $398.4K export value · DGFT Verified

Zydus Lifesciences Limited is the #14 Indian exporter of Febuxostat with $398.4K in export value and 22 verified shipments. Zydus Lifesciences Limited holds a 0.8% market share in Febuxostat exports across 5 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Febuxostat Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Febuxostat export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Febuxostat?

Country	Value	Shipments	Share
UNITED STATES	$350.6K	18	89.0%
KENYA	$19.8K	1	5.0%
SRI LANKA	$12.2K	1	3.1%
TANZANIA	$11.2K	1	2.9%
THAILAND	$8	1

Who Are the Top Buyers of Febuxostat from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$350.6K	18
ABACUS PHARMA (AFRICA) LTD	KENYA	$19.8K	1
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$12.2K	1
ABACUS PHARMA (A) LTD	TANZANIA	$11.2K	1
BJC (BERLI JUCKER PUBLIC COMPANY LI	THAILAND	$8	1

Zydus Lifesciences Limited supplies Febuxostat to 5 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by ABACUS PHARMA (AFRICA) LTD (KENYA) and SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Febuxostat Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
FEBUXOSTAT TABLETS 40 MG - 1 X 30	$70.4K	4
FEBUXOSTAT TABLETS 80 MG - 1 X 30	$60.5K	4
PHARMACEUTICAL MEDICINE FOR HUMAN USE -FEBUXOSTAT TABLETS 40 MG - 1 X 30	$60.2K	3
PHARMACEUTICAL MEDICINE FOR HUMAN USE -FEBUXOSTAT TABLETS 80 MG - 1 X 30	$54.1K	3
PHARMA : FEBUXOSTAT TABLETS 40MG (FEBUXO	$50.0K	1
FEBUXOSTAT TABLETS 80MG (FEBUXOSTAT 80MG	$37.4K	1
ZURIG 80 TABLETS (FEBUXOSTAT TABS 80MG)3X10T	$19.8K	1
ZURIG 40 TABLETS 3X10T(FEBUXOSTAT 40MG)(	$12.2K	1
ZURIG 80 TABLETS(FEBUXOSTAT)(3X10T)	$11.2K	1
FEBUXOSTAT TABLETS 80MG 6336 PACK X 1X30	$10.3K	1

Zydus Lifesciences Limited exports 12 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEBUXOSTAT TABLETS 40 MG - 1 X 30 with 4 shipments worth $70.4K.

How Does Zydus Lifesciences Limited Compare to Nearest Febuxostat Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$449.1K	25	1	$18.0K
13	MYLAN LABORATORIES LIMITED	$414.0K	16	5	$25.9K
14	ZYDUS LIFESCIENCES LIMITED ★	$398.4K	22	5	$18.1K
15	MICRO LABS LIMITED	$392.0K	97	10	$4.0K

Zydus Lifesciences Limited ranks #14 among 182 Indian Febuxostat exporters. Average shipment value of $18.1K compared to the market average of $132.8K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Febuxostat Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	639	18.3%
SAHAR AIR	615	17.6%
DELHI AIR	387	11.1%
SAHAR AIR CARGO ACC (INBOM4)	351	10.0%
NHAVA SHEVA SEA (INNSA1)	145	4.1%
HYDERABAD ICD (INSNF6)	98	2.8%
HYDERABAD AIR	96	2.7%
Bombay Air	84	2.4%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Febuxostat Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 22 individual customs records matching Zydus Lifesciences Limited exporting Febuxostat, covering 12 formulations to 5 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 91+ countries, 421+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Febuxostat

Febuxostat

Zydus Lifesciences Limited — Febuxostat Exporter Profile

Zydus Lifesciences Limited — Febuxostat Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Febuxostat?

Who Are the Top Buyers of Febuxostat from Zydus Lifesciences Limited?

What Is India's Total Febuxostat Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Febuxostat Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Febuxostat Exporters?

What Febuxostat Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Febuxostat to Key Markets

United States — FDA

How Does Zydus Lifesciences Limited Compare to Nearest Febuxostat Exporters?

Which Indian Ports Ship Febuxostat Exports?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Febuxostat Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Febuxostat Export Data from Zydus Lifesciences Limited

Febuxostat Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source